FDA Allows Use of Recombinant BCG Through Expanded Access Program
Recombinant BCG Offers Fresh Promise in Bladder Cancer Care The U.S. Food and Drug Administration (FDA) has approved a new version of the BCG treatment for bladder cancer. This updated …